Opko Health, Inc. financial data

Symbol
OPK on Nasdaq
Industry
Pharmaceutical Preparations
Location
4400 Biscayne Blvd., Miami, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
EXEGENICS INC (to 6/13/2007), eXegenics Inc (to 6/13/2007), CYTOCLONAL PHARMACEUTICS INC /DE (to 6/4/2001)
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 246 % +38.8%
Quick Ratio 28.5 % -14.8%
Debt-to-equity 55.3 % +32.1%
Return On Equity -18 % -163%
Return On Assets -2.53 % +71.9%
Operating Margin -21.3 % -17.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 672M shares -3.65%
Entity Public Float 415M USD -54.1%
Common Stock, Value, Issued 7.02M USD -10.3%
Weighted Average Number of Shares Outstanding, Basic 694M shares -7.68%
Weighted Average Number of Shares Outstanding, Diluted 998M shares +32.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 713M USD -17.4%
Research and Development Expense 105M USD +17.4%
Operating Income (Loss) -152M USD +3.16%
Nonoperating Income (Expense) 142M USD
Income Tax Expense (Benefit) 42.8M USD +866%
Net Income (Loss) Attributable to Parent -53.2M USD +71.8%
Earnings Per Share, Basic -0.07 USD/shares +72%
Earnings Per Share, Diluted -0.09 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 427M USD +345%
Accounts Receivable, after Allowance for Credit Loss, Current 118M USD -4.35%
Inventory, Net 56.8M USD -13.5%
Other Assets, Current 10.7M USD +39.5%
Assets, Current 662M USD +114%
Property, Plant and Equipment, Net 70.1M USD -7.02%
Operating Lease, Right-of-Use Asset 54M USD -20.7%
Intangible Assets, Net (Excluding Goodwill) 617M USD -16.7%
Goodwill 529M USD -11.5%
Other Assets, Noncurrent 18.5M USD +104%
Assets 2.2B USD +9.37%
Accounts Payable, Current 47.1M USD -32.4%
Accrued Liabilities, Current 118M USD +31.4%
Liabilities, Current 193M USD -3.48%
Contract with Customer, Liability, Noncurrent 7K USD -94.9%
Deferred Income Tax Liabilities, Net 141M USD +11.1%
Operating Lease, Liability, Noncurrent 48.8M USD -9.77%
Other Liabilities, Noncurrent 32.8M USD +20.8%
Liabilities 835M USD +34.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -56.1M USD -47.6%
Retained Earnings (Accumulated Deficit) -2.07B USD -2.65%
Stockholders' Equity Attributable to Parent 1.37B USD -1.71%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.55B USD -3.91%
Liabilities and Equity 2.2B USD +9.37%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.6M USD -57%
Net Cash Provided by (Used in) Financing Activities 20.6M USD
Net Cash Provided by (Used in) Investing Activities -4.4M USD +43%
Common Stock, Shares Authorized 1.25B shares 0%
Common Stock, Shares, Issued 701M shares -10.3%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20.2M USD +52.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 446M USD +365%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.13M USD -18.4%
Deferred Tax Assets, Valuation Allowance 227M USD -23.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 179M USD -36.7%
Operating Lease, Liability 61.5M USD -8.4%
Depreciation 15.6M USD -19.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -71.3M USD +61.1%
Lessee, Operating Lease, Liability, to be Paid 73.8M USD -10%
Operating Lease, Liability, Current 12.6M USD -2.67%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11.5M USD -4.44%
Lessee, Operating Lease, Liability, to be Paid, Year One 12.3M USD -8.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +18.5%
Deferred Income Tax Expense (Benefit) -2.68M USD -2727%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.3M USD -17.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.2M USD +6.12%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 16.5M USD -2.49%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.1M USD +7.81%
Operating Lease, Payments 4.33M USD +11.9%
Additional Paid in Capital 3.48B USD +1.41%
Amortization of Intangible Assets 82.6M USD -3.95%
Depreciation, Depletion and Amortization 98.2M USD -6.76%
Interest Expense 17.8M USD +127%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%